Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 30;5(1):e1395504.
doi: 10.1080/23723556.2017.1395504. eCollection 2018.

Dimeric quinacrines as chemical tools to identify PPT1, a new regulator of autophagy in cancer cells

Affiliations

Dimeric quinacrines as chemical tools to identify PPT1, a new regulator of autophagy in cancer cells

Michael C Nicastri et al. Mol Cell Oncol. .

Abstract

DQ661 is a novel dimeric quinacrine that affects multiple lysosomal functions (autophagy and macropinocytosis) and mTORC1 (mechanistic target of rapamycin) activity by specifically targeting protein-palmitoyl thioesterase 1 (PPT1). DQ661 has in vivo activity in immunocompetent mouse models of cancer, and constitutes a new tool compound for the study of lysosomal function in cancer and therapeutic resistance.

Keywords: PPT1; autophagy; lysosome; mTOR; macropinocytosis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schematic summary of the invention of DQ661 (a dimeric quinacrine autophagy/lysosome inhibitor), the identification of Protein Palmitoyl Thioesterase 1 (PPT1), and their influence on lysosomal biology. A) Depicts the chemical strategy in the design and synthesis of lysosomal inhibitor DQ661. Newly described compounds are abbreviated with the identity of their parent heterocycle: dimeric chloroquine (DC), dimeric quinacrine (DQ), dimeric primaquine (DP), and dimeric mefloquine (DM). After the two letter code, the length of the polyamine linker is specified by the first two numbers, and followed by a zero (Unmethylated) or one (methylated) B) Outline of a photoaffinity experiment which identifies PPT1 as a protein binding partner of DQ661 C) Schematic demonstrating how DQ661-mediated inhibition of PPT1 results in the disruption of physical interaction of key protein complexes involved in lysosomal acidification and mTORC1 (mechanistic target of rapamycin) activation.

References

    1. Ma XH, Piao SF, Dey S, McAfee Q, Karakousis G, Villanueva J, Hart LS, Levi S, Hu J, Zhang G, et al.. Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma. The Journal of clinical investigation. 2014;124(3):1406–1417. - PMC - PubMed
    1. Rangwala R, Chang YC, Hu J, Algazy KM, Evans TL, Fecher LA, Schuchter LM, Torigian DA, Panosian JT, Troxel AB, et al.. Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma. Autophagy. 2014;10(8):1391–402. - PMC - PubMed
    1. Mahalingam D, Mita M, Sarantopoulos J, Wood L, Amaravadi RK, Davis LE, Mita AC, Curiel TJ, Espitia CM, Nawrocki ST, et al.. Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors. Autophagy. 2014;10(8):1403–14. - PMC - PubMed
    1. McAfee Q, Zhang Z, Samanta A, Levi SM, Ma XH, Piao S, Lynch JP, Uehara T, Sepulveda AR, Davis LE, et al.. Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency. Proceedings of the National Academy of Sciences of the United States of America. 2012;109(21):8253–8. [Pmc3361415] - PMC - PubMed
    1. Rebecca VW, Nicastri MC, McLaughlin N, Fennelly C, McAfee Q, Ronghe A, Nofal M, Lim CY, Witze E, Chude CI, et al.. A unified approach to targeting the lysosome's degradative and growth signaling roles. Cancer Discov. 2017. - PMC - PubMed

LinkOut - more resources